Novel Coronavirus Pneumonia
📧 Sign up to get email alerts when something new happens for Novel Coronavirus Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19 [Phase 3]
Phase 3 trial of Tanreqing Capsules for novel coronavirus pneumonia (COVID-19) completed.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 [Phase 1, Phase 2]
Clinical trial update on using exosomes for acute respiratory distress syndrome or COVID-19 related pneumonia (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Effects of Fuzheng Huayu Tablets on COVID-19 [Phase 4]
Phase 4 trial evaluating Fuzheng Huayu Tablets for Novel Coronavirus Pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Protective Effect of Aspirin on COVID-19 Patients [Phase 2, Phase 3]
A clinical trial update investigating the protective effect of aspirin in patients with COVID-19 across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia [Phase 2, Phase 3]
A clinical trial update for favipiravir tablets combined with chloroquine phosphate in the treatment of Novel Coronavirus Pneumonia (Phase 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of pirfenidone for novel coronavirus pneumonia/pneumonia is in unknown status.